Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Study Results
Related Studies
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
This study has been terminated.
( Low Accrual. )
Study NCT00726830 Information provided by M.D. Anderson Cancer Center
First Received on July 31, 2008. Last Updated on November 9, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leukemia
Lymphoma
Lymphoproliferative Disorder
Myelodysplastic Syndromes
Pain
Precancerous Condition
Additional conditions recognized in this trial
Central Nervous System Neoplasms
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin
Lymphoproliferative Disorders
Multiple Myeloma
Myelodysplastic-Myeloproliferative Diseases
Myeloproliferative Disorders
Neoplasms
Neoplasms, Plasma Cell
Nervous System Neoplasms
Plasmacytoma
Precancerous Conditions
Preleukemia
More general conditions related to this trial
Blood Protein Disorders
Bone Marrow Diseases
Cardiovascular Diseases
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Neoplasms by Histologic Type
Neoplasms by Site
Nervous System Diseases
Paraproteinemias
Vascular Diseases
Interventions listed in this trial
methadone hydrochloride
morphine sulfate
oxycodone hydrochloride
Additional drug interventions recognized in this trial
Analgesics, Opioid
Methadone
Morphine
Oxycodone
More general drug interventions related to this trial
Analgesics
Antitussive Agents
Central Nervous System Agents
Central Nervous System Depressants
Narcotics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Back to top of Main Content
